91 related articles for article (PubMed ID: 12628750)
1. Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage.
Meli E; Pangallo M; Baronti R; Chiarugi A; Cozzi A; Pellegrini-Giampietro DE; Moroni F
Toxicol Lett; 2003 Apr; 139(2-3):153-62. PubMed ID: 12628750
[TBL] [Abstract][Full Text] [Related]
2. PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice.
Chen YL; Wang Y; Fang QY; Wang T; Chen C; Gao TY; Wu M; Zhang WP; Lu YB
Eur J Pharmacol; 2024 Mar; 967():176377. PubMed ID: 38346469
[TBL] [Abstract][Full Text] [Related]
3. A Review of PARP-1 Inhibitors: Assessing Emerging Prospects and Tailoring Therapeutic Strategies.
Ramesh S; Almeida SD; Hammigi S; Radhakrishna GK; Sireesha G; Panneerselvam T; Vellingiri S; Kunjiappan S; Ammunje DN; Pavadai P
Drug Res (Stuttg); 2023 Nov; 73(9):491-505. PubMed ID: 37890514
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity.
Eisemann T; Pascal JM
Cell Mol Life Sci; 2020 Jan; 77(1):19-33. PubMed ID: 31754726
[TBL] [Abstract][Full Text] [Related]
5. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
Pacher P; Szabó C
Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
[TBL] [Abstract][Full Text] [Related]
6. Effect of carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia.
Strosznajder RP; Jesko H; Dziewulska J
Acta Neurobiol Exp (Wars); 2005; 65(2):137-43. PubMed ID: 15960297
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) mediates bioenergetic defects and redox imbalance in neurons following oxygen and glucose deprivation.
Hossain MI; Lee JH; Gagné JP; Khan J; Poirier GG; King PH; Dawson VL; Dawson TM; Andrabi SA
FASEB J; 2024 Mar; 38(6):e23556. PubMed ID: 38498348
[TBL] [Abstract][Full Text] [Related]
8. The effects of organic solvents on poly(ADP-ribose) polymerase-1 activity: implications for neurotoxicity.
Banasik M; Stedeford T; Strosznajder RP; Persad AS; Tanaka S; Ueda K
Acta Neurobiol Exp (Wars); 2004; 64(4):467-73. PubMed ID: 15586663
[TBL] [Abstract][Full Text] [Related]
9. Nuclear PARPs and genome integrity.
Azarm K; Smith S
Genes Dev; 2020 Mar; 34(5-6):285-301. PubMed ID: 32029453
[TBL] [Abstract][Full Text] [Related]
10. No Silver Bullet - Canonical Poly(ADP-Ribose) Polymerases (PARPs) Are No Universal Factors of Abiotic and Biotic Stress Resistance of
Rissel D; Heym PP; Thor K; Brandt W; Wessjohann LA; Peiter E
Front Plant Sci; 2017; 8():59. PubMed ID: 28220129
[TBL] [Abstract][Full Text] [Related]
11. First body of evidence suggesting a role of a tankyrase-binding motif (TBM) of vinculin (VCL) in epithelial cells.
Vilchez Larrea S; Valsecchi WM; Fernández Villamil SH; Lafon Hughes LI
PeerJ; 2021; 9():e11442. PubMed ID: 34123588
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Poly(ADP-Ribose) Polymerase by Nucleic Acid Metabolite 7-Methylguanine.
Nilov DK; Tararov VI; Kulikov AV; Zakharenko AL; Gushchina IV; Mikhailov SN; Lavrik OI; Švedas VK
Acta Naturae; 2016; 8(2):108-15. PubMed ID: 27437145
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta protein affects poly(ADP-ribose) polymerase activity in PC-12 cells in culture.
Strosznajder RP; Banasik M
Acta Neurobiol Exp (Wars); 2000; 60(2):215. PubMed ID: 10909178
[No Abstract] [Full Text] [Related]
14. Characterization of PARP6 Function in Knockout Mice and Patients with Developmental Delay.
Vermehren-Schmaedick A; Huang JY; Levinson M; Pomaville MB; Reed S; Bellus GA; Gilbert F; Keren B; Heron D; Haye D; Janello C; Makowski C; Danhauser K; Fedorov LM; Haack TB; Wright KM; Cohen MS
Cells; 2021 May; 10(6):. PubMed ID: 34067418
[TBL] [Abstract][Full Text] [Related]
15. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration.
Chaitanya GV; Steven AJ; Babu PP
Cell Commun Signal; 2010 Dec; 8():31. PubMed ID: 21176168
[TBL] [Abstract][Full Text] [Related]
16. Effects of alcohol and PARP inhibition on RNA ribosomal engagement in cortical excitatory neurons.
Krishnan HR; Vallerini GP; Gavin HE; Guizzetti M; Rizavi HS; Gavin DP; Sharma RP
Front Mol Neurosci; 2023; 16():1125160. PubMed ID: 37113267
[TBL] [Abstract][Full Text] [Related]
17. Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.
Tiwari P; Khan H; Singh TG; Grewal AK
Neurochem Res; 2022 Jul; 47(7):1830-1852. PubMed ID: 35437712
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial function in hypoxic ischemic injury and influence of aging.
Ham PB; Raju R
Prog Neurobiol; 2017 Oct; 157():92-116. PubMed ID: 27321753
[TBL] [Abstract][Full Text] [Related]
19. Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury.
Li Q; Han X; Wang J
Mol Neurobiol; 2016 Aug; 53(6):4226-4237. PubMed ID: 26223803
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms Underlying Cell Death in Spinal Networks in Relation to Locomotor Activity After Acute Injury in vitro.
Kuzhandaivel A; Nistri A; Mazzone GL; Mladinic M
Front Cell Neurosci; 2011; 5():9. PubMed ID: 21734866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
